About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Texas | 41,977 Studies Near You

Clinical TrialsTexas

Clinical Trials in Texas

Discover 41,977 clinical trials near Texas. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 461-480 of 41,977 trials

RecruitingA Phase 2 Study to Evaluate Therapies for Inflammatory Bowel DiseaseThis is a Phase 2, multicenter, platform study in adult participants with IBD (moderately to severely active Crohn's Disease or Ulcerative Colitis).NCT07113522·Birmingham, Alabama and 65 others

Find Trials by Condition in Texas

Breast Cancerin Texas Lung Cancerin Texas Prostate Cancerin Texas Colorectal Cancerin Texas Melanomain Texas Leukemiain Texas Lymphomain Texas Pancreatic Cancerin Texas Ovarian Cancerin Texas Brain Cancerin Texas Diabetesin Texas

Data from ClinicalTrials.govTerms

Active not recruitingSELUTION SLR™ 014 In-stent RestenosisProspective, multi-center, randomized, single blind, controlled, noninferiority clinical trial.NCT04280029·Loma Linda, California and 47 others

RecruitingZenith® Fenestrated+ Clinical StudyThe Zenith® Fenestrated+ Endovascular Graft Clinical Study will assess the safety and effectiveness of the Zenith® Fenestrated+ Endovascular Graft (ZFEN+) in combination with the…NCT04875429·Birmingham, Alabama and 32 others

TerminatedAntineoplaston Therapy in Treating Patients With Stage IV Pancreatic CancerCurrent therapies for Stage IV Pancreatic Cancer provide very limited benefit to the patient.NCT00003531·Houston, Texas

WithdrawnAntineoplaston Therapy in Treating Patients With Mantle Cell LymphomaRATIONALE: Antineoplastons are naturally-occurring substances that may also be made in the laboratory. Antineoplastons may inhibit the growth of cancer cells.NCT00003502·Houston, Texas

CompletedA Study of Intravenous or Subcutaneous Methoxy Polyethylene Glycol-Epoetin Beta (RO0503821, Mircera) in Chronic Kidney Disease Patients With Renal AnemiaThis study assessed the long-term efficacy, safety, and tolerability of intravenous (iv) or subcutaneous (sc) methoxy polyethylene glycol-epoetin beta in chronic kidney disease…NCT00090753·Birmingham, Alabama and 248 others

Active not recruitingCapivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN DeficiencyThis study will assess the efficacy and safety of capivasertib plus abiraterone (+prednisone/prednisolone) plus androgen deprivation therapy (ADT) versus placebo plus abiraterone…NCT04493853·Tucson, Arizona and 322 others

Active not recruitingThe MOTION Study - Treatment of LSS With the MILD ProcedureProspective, multicenter, randomized controlled clinical study examining functional improvement in lumbar spinal stenosis (LSS) patients with neurogenic claudication who are…NCT03610737·Newport Beach, California and 17 others

RecruitingRadiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone SurgeryThis phase II trial studies how well radiation therapy with or without cisplatin works in treating patients with stage III-IVA squamous cell carcinoma of the head and neck who…NCT02734537·Birmingham, Alabama and 678 others

CompletedMTD Study of Vaccine BP-GMAX-CD1 Plus AP1903 to Treat Castrate Resistant Prostate CancerThis is a Phase I, non-randomized, multiple-dose, 3+3 dose-escalation study of the safety, pharmacokinetics, biomarkers, preliminary efficacy and patient-reported outcomes of…NCT00868595·Houston, Texas

CompletedPharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.This study is a randomized, double-blind, placebo-controlled, three-period cross-over study in approximately 54 subjects with asthma.NCT03257995·North Dartmouth, Massachusetts and 5 others

Active not recruitingA Study of AB801 Monotherapy and Combination Therapy in Participants With Advanced MalignanciesThe primary purpose of this study is to assess the safety and tolerability of AB801 in participants with advanced malignancies, and to determine a recommended AB801 dose for…NCT06120075·Denver, Colorado and 9 others

RecruitingDevelopment of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD DementiaBio-Hermes-002 is a 120-day cross-sectional study that will result in a blood, CSF, retinal, digital, MRI, and PET brain imaging biomarker database that can be used to determine…NCT06584357·Atlantis, Florida and 25 others

CompletedA Study of Budigalimab (ABBV-181) in Participants With Advanced Solid TumorsThis is an open-label, Phase I, dose-escalation study to determine the recommended Phase 2 dose (RPTD), maximum tolerated dose (MTD), and evaluate the safety and pharmacokinetic…NCT03000257·La Jolla, California and 25 others

WithdrawnMaraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected PatientsConfirm the safety of maraviroc when used as a component of combination antiretroviral therapy in HIV and Hepatitis co-infected patients.NCT00782301·Clearwater, Florida and 17 others

CompletedTopical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1)This study is a prospective, randomized, double-blind, placebo-controlled evaluation of the safety of a topically applied formulation of rapamycin to cutaneous fibromatous lesions…NCT01031901·Houston, Texas

RecruitingCTX-009 With Gemcitabine, Cisplatin, and Durvalumab as First-line Therapy in Patients With Unresectable or Metastatic Biliary Tract CancersTo evaluate combination therapy of adding CTX-009 to the standard therapy GCD as first-line therapy in patients with unresectable or mBTC.NCT06548412·Houston, Texas

CompletedEfficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast CancerThe purpose of this study is to determine if enzalutamide given in combination with exemestane is safe and effective in patients with advanced breast cancer.NCT02007512·Aurora, Colorado and 134 others

CompletedA Study of ARQ 501 in Patients With Squamous Cell Carcinoma of the Head and NeckThis is a Phase 2, multi-center, open label study of ARQ 501 in patients with locally advanced, recurrent or metastatic squamous cell cancer of the head and neck (SCCHN).NCT00358930·Mobile, Alabama and 8 others

CompletedEffect of Whey Protein Hydrolysate on Human Muscle Protein SynthesisMuscle protein synthesis can be stimulated by ingestion of protein sources, such as whey, casein or soy.NCT03313830·Galveston, Texas

PreviousPage 24 of 2099Next

Heart Diseasein Texas